Philips and Glygenix partner to deliver gene therapy with ultrasound – UPDATE
This article was originally published in Clinica
Executive Summary
Royal Philips Electronics is to team up with private biotech concern GlyGenix Therapeutics to research the use of ultrasound technologies to deliver gene therapy.
You may also be interested in...
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.